About Sepracor
Sepracor is a company based in Marlborough (United States) founded in 1984 was acquired by Sumitomo Dainippon Pharma in September 2009. Sepracor offers products and services including Drug Pipeline and Clinical Trials.
- Headquarter Marlborough, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sumitomo Pharma America, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Sumitomo Dainippon Pharma
(Sep 03, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sepracor
Sepracor offers a comprehensive portfolio of products and services, including Drug Pipeline and Clinical Trials.
Advances preclinical and clinical programs for various health needs
Conducts trials to develop treatments for rare diseases and more
Funding Insights of Sepracor
Detailed funding history for Sepracor
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Sepracor
Sepracor has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sumitomo Dainippon Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceuticals, food ingredients, additives, and veterinary products are manufactured.
|
Locked | Locked | Locked |
Investor details for Sepracor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sepracor
Investment portfolio details for Sepracor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sepracor
Detailed financials for Sepracor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sepracor Comparisons
Peer comparison for Sepracor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sepracor
Detailed competitors of Sepracor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sepracor
Complete news archive for Sepracor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sepracor
Sepracor was founded in 1984.
Sepracor is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.
Saburo Hamanaka is the current CEO of Sepracor.
In July 2010, Sepracor and Dainippon Sumitomo Pharma (DSP), an Osaka, Japan-based pharma company, announced the intent to change the Sepracor name to Sunovion Pharmaceuticals. DSP acquired Sepracor in October 2009 and the name change was planned to occur in anticipation of the one-year anniversary of the acquisition. Sepracors drug development program, together with its corporate development and licensing efforts, has yielded a portfolio of pharmaceutical products and candidates with a focus on respiratory and central nervous system disorders. Currently, marketed products include LUNESTA brand eszopiclone, XOPENEX brand levalbuterol HCl Inhalation Solution, XOPENEX HFA brand levalbuterol tartrate Inhalation Aerosol, BROVANA brand arformoterol tartrate Inhalation Solution, OMNARIS brand ciclesonide Nasal Spray and ALVESCO brand ciclesonide HFA Inhalation Aerosol.
Sepracor offers Drug Pipeline and Clinical Trials.
Sepracor has 1 investor. Key investors include Sumitomo Dainippon Pharma.